Intrinsic Value

The intrinsic value of Shanghai Medicilon Inc (688202) under the Base Case is 57.95 CNY per share. Compared with the current market price of 74.52 CNY, the stock appears Overvalued by 22% .

The intrinsic value is calculated using valuation multiples.

Do our valuations actually work? See backtest results .

Intrinsic Value
¥57.95
Overvaluation 22%
Intrinsic Value
Price ¥74.52
Alert me when Shanghai Medicilon Inc is below its intrinsic value
Today ¥46.36 · 37.8% below the current price

Shanghai Medicilon Inc is valued in line with its history. A premium of this size has been typical over the past 5 years.

Alternatives to Shanghai Medicilon Inc

Fundamental Analysis

What Shanghai Medicilon Does

Life Sciences Tools & Services Health Care

Shanghai Medicilon Inc. is a drug research and development services company. It helps pharmaceutical and biotech clients move new medicines from early discovery into preclinical testing by running chemistry, biology, pharmacology, drug metabolism, and safety studies. In plain terms, it is a research partner that does much of the lab work needed before a drug candidate can enter human trials.

Headquarters
China CN
Employees
2 440
IPO date
Nov 5, 2019
Read the full company overview
View Company Overview
Financials
Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Continue Research

Decided on Shanghai Medicilon? Get an email when Shanghai Medicilon Inc reaches the price you’d buy at. Free with an account.

What is the Intrinsic Value of one Shanghai Medicilon Inc stock?

The intrinsic value for Shanghai Medicilon Inc (688202) under the Base Case is 57.95 CNY.

Is Shanghai Medicilon Inc stock undervalued or overvalued?

Compared with the current market price of 74.52 CNY, the stock appears Overvalued by 22% .

How reliable are our estimates? See how past valuations played out
Back to Top